{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:36:56Z","timestamp":1778690216829,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373943"],"award-info":[{"award-number":["81373943"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573583"],"award-info":[{"award-number":["81573583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Provincial Science and Technology Department of Youth Science and technology innovation research team program","award":["2017TD0001"],"award-info":[{"award-number":["2017TD0001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U19A2010"],"award-info":[{"award-number":["U19A2010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biopha.2020.110138","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T13:03:42Z","timestamp":1588683822000},"page":"110138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["2,3,5,4'-tetrahydroxystilbence-2-O-\u03b2-D-glucoside attenuates hepatic steatosis via IKK\u03b2\/NF-\u03baB and Keap1-Nrf2 pathways in larval zebrafish"],"prefix":"10.1016","volume":"127","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110138_bib0005","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S, Food and Drug Administration Joint Workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110138_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110138_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jphs.2017.11.007","article-title":"Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy","volume":"136","author":"Gong","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-016-4095-4","article-title":"Natural history of nonalcoholic fatty liver disease","volume":"61","author":"Goh","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2017.04.005","article-title":"Chymase inhibitor prevents the development and progression of?nOn-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet","volume":"134","author":"Miyaoka","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0030","first-page":"185","article-title":"Sarcopenic obesity in fatty liver","volume":"22","author":"Merli","year":"2019","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2020.110138_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/ceh.2018.78120","article-title":"A systematic review of the present and future of non-alcoholic fatty liver disease","volume":"4","author":"Lucas","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.biopha.2020.110138_bib0040","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2020.110138_bib0045","first-page":"130","article-title":"Role of probiotics in the treatment of nonalcoholic fatty liver disease: a meta-analysis","volume":"7","author":"A.L. S","year":"2017","journal-title":"Euroasian J. Hepatogastroenterol."},{"key":"10.1016\/j.biopha.2020.110138_bib0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jphs.2014.12.001","article-title":"Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats","volume":"127","author":"Li","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700479","article-title":"Supplementation with docosahexaenoic acid and extra virgin olive oil prevents liver steatosis induced by a high-fat diet in mice through PPAR-\u03b1 and Nrf2 upregulation with concomitant SREBP-1c and NF-kB downregulation","volume":"61","author":"Hern\u00e1ndez-Rodas","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2020.110138_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jnutbio.2018.09.012","article-title":"Reduction of high-fat diet-induced liver proinflammatory state by eicosapentaenoic acid plus hydroxytyrosol supplementation: involvement of resolvins RvE1\/2 and RvD1\/2","volume":"63","author":"Echeverr\u00eda","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2020.110138_bib0065","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110138_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-020-0384-9","article-title":"In vitro and in situ study on characterization and mechanism of the intestinal absorption of 2,3,5,4\u2019-tetrahydroxy-stilbene-2-O-beta-D-glucoside","volume":"21","author":"Wang","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110138_bib0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jep.2014.03.042","article-title":"In vitro effects of active components of Polygonum multiflorum Radix on enzymes involved in the lipid metabolism","volume":"153","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.110138_bib0080","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3641960","article-title":"Polygonum multiflorum biological effects of tetrahydroxystilbene glucoside: an active component of a rhizome extracted from","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2020.110138_bib0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1152\/physrev.00038.2016","article-title":"Little Fish, big data: zebrafish as a model for cardiovascular and Metabolic Disease","volume":"97","author":"Gut","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2020.110138_bib0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110138_bib0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.biopha.2017.11.029","article-title":"Zuogui Pill improves the dexamethasone-induced osteoporosis progression in zebrafish larvae","volume":"97","author":"Yin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110138_bib0100","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopha.2018.05.081","article-title":"Protective effects of cichoric acid on H2O2-induced oxidative injury in hepatocytes and larval zebrafish models","volume":"104","author":"Ma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110138_bib0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/ijbs.30013","article-title":"A comprehensive study of high cholesterol diet-induced larval zebrafish model: a short-time in vivo screening method for non-alcoholic fatty liver disease drugs","volume":"15","author":"Ma","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/BJ20100293","article-title":"Zebrafish: gaining popularity in lipid research","volume":"429","author":"Holtta-Vuori","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2020.110138_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jphs.2018.09.012","article-title":"Lipid-modulate activity of Cichorium glandulosum Boiss. Et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model","volume":"138","author":"Li","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0120","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/564705","article-title":"Ezetimibe and simvastatin reduce cholesterol levels in zebrafish larvae fed a high-cholesterol diet","author":"Baek","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.biopha.2020.110138_bib0125","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1242\/jeb.204.24.4335","article-title":"Growth and metabolism of larval zebrafish: effects of swim training","volume":"204","author":"Bagatto","year":"2001","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.biopha.2020.110138_bib0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081984","article-title":"Lipid modulating anti-oxidant stress activity of Gastrodin on nonalcoholic fatty liver disease larval zebrafish model","volume":"20","author":"Ahmad","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0135","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s40064-015-1542-1","article-title":"Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review","volume":"4","author":"Zhang","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.biopha.2020.110138_bib0140","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijcard.2012.09.085","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"167","author":"Brea","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110138_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010040","article-title":"Sphingolipids in non-alcoholic fatty liver disease and hepatocellular carcinoma: ceramide turnover","volume":"21","author":"Simon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0150","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00109-019-01845-2","article-title":"Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases","volume":"98","author":"Nguyen","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.biopha.2020.110138_bib0160","first-page":"848","article-title":"[Oxidative stress and heart failure]","volume":"64","author":"Kinugawa","year":"2011","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.biopha.2020.110138_bib0165","doi-asserted-by":"crossref","first-page":"32110","DOI":"10.1038\/srep32110","article-title":"Lack of association between SREBF-1c gene polymorphisms and risk of non-alcoholic fatty liver disease in a Chinese Han population","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110138_bib0170","doi-asserted-by":"crossref","first-page":"E5896","DOI":"10.1073\/pnas.1801745115","article-title":"Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis","volume":"115","author":"Dai","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110138_bib0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0033-1358520","article-title":"Bile acid-mediated control of liver triglycerides","volume":"33","author":"Fuchs","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2020.110138_bib0180","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1172\/JCI90327","article-title":"Hepatocyte nuclear factor 1\u03b1 suppresses steatosis-associated liver cancer by inhibiting PPAR\u03b3 transcription","volume":"127","author":"Patitucci","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110138_bib0185","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2020.110138_bib0190","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1039\/C9FO01373C","article-title":"High-fat diet induces mouse liver steatosis with a concomitant decline in energy metabolism: attenuation by eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation and the additive effects upon EPA and HT co-administration","volume":"10","author":"Echeverr\u00eda","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2020.110138_bib0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/mnfr.201300458","article-title":"N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-\u03b1 upregulation and NF-\u03baB DNA binding abrogation","volume":"58","author":"Tapia","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2020.110138_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications","volume":"13","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.biopha.2020.110138_bib0205","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbadis.2009.08.015","article-title":"Enhancement in liver SREBP-1c\/PPAR-\u03b1 ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion","volume":"1792","author":"Pettinelli","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.110138_bib0210","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.2147\/OTT.S199161","article-title":"Abietic acid suppresses non-small-cell lung cancer cell growth via blocking IKKbeta\/NF-kappaB signaling","volume":"12","author":"Liu","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.biopha.2020.110138_bib0215","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/sj.onc.1209934","article-title":"IkappaB kinase complexes: gateways to NF-kappaB activation and transcription","volume":"25","author":"Scheidereit","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2020.110138_bib0220","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2020.110138_bib0225","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1021\/es502855x","article-title":"Iodoacetic acid activates Nrf2-mediated antioxidant response in vitro and in vivo","volume":"48","author":"Wang","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.biopha.2020.110138_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.115.231316","article-title":"Nuclear factor erythroid 2-Related factor 2 deficiency results in amplification of the liver fat-lowering effect of estrogen","volume":"358","author":"Rui","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.110138_bib0235","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/C7FO00090A","article-title":"Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-\u03b1 and Nrf2 activation, and NF-\u03baB down-regulation","volume":"8","author":"Valenzuela","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2020.110138_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1871530317666171114120552","article-title":"Liver protective effects of extra virgin olive oil: interaction between its chemical composition and the cell-signaling pathways involved in protection","volume":"18","author":"Soto-Alarcon","year":"2018","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2020.110138_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cardiores.2007.04.004","article-title":"Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression","volume":"75","author":"Mann","year":"2007","journal-title":"Cardiovasc. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220303309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220303309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:55:49Z","timestamp":1760097349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220303309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"alternative-id":["S0753332220303309"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110138","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2,3,5,4'-tetrahydroxystilbence-2-O-\u03b2-D-glucoside attenuates hepatic steatosis via IKK\u03b2\/NF-\u03baB and Keap1-Nrf2 pathways in larval zebrafish","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110138"}}